Malabar India Fund Limited reduced its stake in Neuland Laboratories from 7.18% to 5.06% by selling 2,72,634 shares in the open market on August 14, 2026.
A pharmaceutical manufacturer engaged in the production and distribution of bulk drugs, Neuland Labs serves both domestic and international markets through its integrated operations. The company specializes in manufacturing active pharmaceutical ingredients and provides contract manufacturing services to global pharmaceutical companies. Its facilities are designed to meet stringent international quality and regulatory standards for pharmaceutical production.
India dedicated FPI founded in 2008 by Sumeet Nagar (ex-McKinsey PE) and Akshay Mansukhani. Focuses on under-researched Indian small and midcap businesses with a long-term horizon, sifting 7,000+ listed companies before making concentrated bets. One of India's best-known FPI smallcap specialists, known for multi-year compounder picks.
